When we challenge boundaries, we advance interventional radiology
Interventional Radiology
Committed to Interventional Oncology
Boston Scientific is committed to advancing the treatment of cancer and other complex interventional procedures worldwide.
TheraSphere receives FDA Approval!
After 20 years as a humanitarian exemption device (HDE), the FDA grants TheraSphere pre-market approval, making TheraSphere the only Y-90 therapy indicated for HCC. This means institutional review board (IRB) approval of TheraSphere is no longer required by the FDA.
Eluvia™ Drug-Eluting Stent and Ranger™ Drug-Coated Balloon
Boston Scientific is committed to advancing science in the fight against PAD. Our proven results are backed by Level-1 Randomized Controlled Trials.
Reimbursement
Resources for patients and healthcare professionals.
Product Catalogs
View and download the coronary and peripheral vascular product catalogs.
Talk to a representative
Want to learn more about products and services? One of our sales representatives will be happy to contact you.
Get updates
Stay up-to-date with emails on the latest advances, news and innovations in interventional radiology.
Sign up for training
Our specialized training and expert support focuses on improving your skills.
TheraSphere is a registered trademark of Theragenics Corporation used under license by Biocompatibles UK Ltd., a wholly owned subsidiary of Boston Scientific Corporation.